Jonathan Violin, Chief Executive Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 60,000 shares at $17.36 ($1.1M) on 2022-03-02, disclosed to the SEC on 2022-03-03.
Open-market sale of $1.1M VRDN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.82 | 18,894 | $337K | 31.8% |
| 2 | $17.82 | 18,894 | $337K | 31.8% |
| 3 | $17.36 | 11,106 | $193K | 18.2% |
| 4 | $17.36 | 11,106 | $193K | 18.2% |
| Total | $17.65 avg | 60,000 | $1.1M | 100% |
| Filing → |
| VRDN | SELL | 2022-05-04 | $391K | — | Filing → |
| VRDN | SELL | 2022-04-05 | $1.1M | — | Filing → |
| VRDN | SELL | 2022-02-03 | $1.1M | — | Filing → |